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Human MxA protein is a type I interferon-inducible intracytoplasmic protein, which mediates antiviral actions against a
variety of negative-strand RNA viruses including influenza A, measles, and vesicular stomatitis viruses. Recently, it has also
been shown that several members of the Bunyaviridae family are inhibited by MxA protein. The hantavirus genus in the
Bunyaviridae family includes important human pathogenic viruses, e.g., Puumala (PUUV), Hantaan, and Sin Nombre viruses.
Tula virus (TULV) is a new member of the genus, but its pathogenicity in man remains to be determined. As assumed by
the similarities in replication strategy, MxA would be a good candidate molecule for antiviral action against these viruses,
also. To gain more insight into the MxA action on PUUV, we studied PUUV and TULV replication in stably MxA gene-
transfected Vero cells. We show that MxA protein has the capacity to inhibit both viral protein and RNA accumulation in
virus-infected cells. We also studied PUUV and TULV infection in MxA-transfected U-937 cell clones. In these cell lines
both hantaviruses grew poorly, independent of whether the cells were expressing MxA or not. Whether cell line-specific
differences in the antiviral activity of MxA protein against hantaviruses exist cannot be conclusively determined due to the
lack of productive infection of PUUV and TULV in U-937 cells. q 1996 Academic Press, Inc.
INTRODUCTION ratory distress and noncardiogenic pulmonary edema
(Nichol et al., 1993; Hjelle et al., 1994b, 1995a,b, 1996;
Hantaviruses are enveloped negative-strand RNA vi-
Morzunov et al., 1995; Ravkov et al., 1995; Song et al.,
ruses with three genome segments: short (S) segment
1995). All hantavirus infections are transmitted to humans
encoding the nucleocapsid (N), medium (M) segment en-
from their natural hosts, rodents and insectivores. Tula
coding two glycoproteins, and long (L) segment encoding
virus (TULV) was recently identified and isolated from
RNA polymerase/transcriptase (Elliott et al., 1991). The
European common voles and is genetically most closely
hantavirus genus of the Bunyaviridae family consists to
related to PUUV, SNV, and Prospect Hill and Khabarovsk
date of at least 18 human pathogenic or apathogenic
viruses (Plyusnin et al., 1994; Ho¨rling et al., 1996; Vapa-
viruses. The most important human pathogens include
lahti et al., in press). Of these viruses, Prospect Hill virus
Hantaan (HTNV) and Seoul viruses (SEOV), which cause
is considered apathogenic (Lee et al., 1985), whereas
hemorrhagic fever with renal syndrome (HFRS) mainly in
the pathogenicity of TULV and Khabarovsk virus remains
China and Korea, with a mortality of 1–10%, SEOV caus-
to be determined (Plyusnin et al., 1994; Ho¨rling et al.,
ing a somewhat milder disease (Lee et al., 1990). Puu-
1996).
mala virus (PUUV) is endemic in Scandinavia, European Externally added or virus-induced type I interferons
Russia, the Balkans, and also some parts of Central Eu- (IFNs) have been shown to inhibit hantavirus replication
rope. PUUV infection, i.e., nephropathia epidemica (NE), in vitro (Tamura et al., 1987; Pensiero et al., 1992; Temo-
is a mild form of HFRS. It is characterized by fever, head- nen et al., 1995). However, the use of IFN as an antiviral
ache, abdominal and back pains, and acute reversible drug in HTNV infection has not been promising (Gui et
tubulointerstitial nephritis with decreased urine output, al., 1987), possibly due to the fact that viremia is often
proteinuria, and hematuria (La¨hdevirta, 1971; Mustonen over by the time the symptoms of the disease appear.
et al., 1994a,b). Hemorrhages and shock, the main The antiviral effects of type I interferons (IFN-a and -b)
causes of mortality in HTNV and SEOV infections, are are mediated by at least three different protein systems,
less frequently encountered in NE. 2*,5*-oligoadenylate synthetase/RNase L, dsRNA-acti-
During the past few years at least eight new hantavi- vated protein kinase (PKR), and Mx protein (Sen and
ruses indigenous to the Americas have been identified Ransohoff, 1993). Human MxA, a cytoplasmic 76-kDa pro-
following the outbreak of Sin Nombre virus (SNV) in 1993, tein, inhibits several negative-strand RNA viruses includ-
which often causes a fatal febrile illness with acute respi- ing influenza A (Pavlovic et al., 1990), Thogoto (Orthomyx-
oviridae) (Frese et al., 1995) and vesicular stomatitis (VS)
viruses (Rhabdoviridae) (Pavlovic et al., 1990; Staeheli1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /358-0-434 6491; E-mail: Mari.Kanerva@helsinki.fi. and Pavlovic, 1991). The mechanism of action of MxA
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protein remains to be defined, but it seems to inhibit ent to culture plates. Human peripheral blood mononu-
clear cells (PBMC) from healthy blood donors were ob-different steps of the replication cycle of the virus, de-
pending on the virus in question and its site of replication tained from the Finnish Red Cross blood transfusion cen-
ter, Helsinki, and used for estimating physiological MxA(Zu¨rcher et al., 1992). MxA protein is known to interfere
with the primary transcription of VSV in the cytoplasm protein levels. PBMC were cultivated and stimulated with
IFN-a (1000 IU/ml, 24 hr) as described (Ronni et al., 1993).(Staeheli and Pavlovic, 1991). In MxA-expressing cells
primary transcription of both influenza A and Thogoto Human A549 cells (ATCC CCL 185) were maintained in
MEM with antibiotics and 10% FCS and were stimulatedviruses occurs normally in the nucleus, whereas subse-
quent steps in viral replication and protein synthesis are with IFN-a as above.
inhibited by MxA protein (Pavlovic et al., 1992; Frese et
al., 1995). In measles virus infection MxA protein-medi- Viruses
ated inhibition seems to be cell-type specific. In the U-
The prototype Sotkamo strain of PUUV adapted to Vero937 monocytic cell line stably transfected with MxA gene,
E6 cells (Schmaljohn et al., 1985) was used in passagesMxA protein reduced the production of infectious virus
9–11 and TULV (Vapalahti et al., in press) in passage 4.by disturbing measles virus glycoprotein synthesis,
PUUV and TULV were produced and their titers werewhereas measles viral mRNA and N, M, and P protein
determined in Vero E6 cells. The infection was carriedsynthesis did not seem to be inhibited (Schnorr et al.,
out using the highest achievable concentration of PUUV1993). However, in MxA-transfected U-87 glioblastoma
(0.005 PFU/cell) or TULV (0.13 PFU/cell). After absorptioncells measles virus infection is restricted at a transcrip-
for 1 hr at 377 the virus inoculum was removed and re-tional level (Schneider-Schaulies et al., 1994).
placed by fresh medium with 2% FCS. All handling of liveRecently, it has been shown that several members of
virus was performed in a biosafety level 3 laboratory.the Bunyaviridae family are inhibited by MxA protein
(Frese et al., 1996). In a previous study we demonstrated
Sample collectionthat IFNs dose-dependently inhibited PUUV replication
in monocyte/macrophages, but in MxA-transfected Cell samples were collected in phosphate-buffered sa-
monocytic cells accumulation of PUUV N protein ap- line (PBS)/ 0.1% sodium dodecyl sulfate (SDS) for immu-
peared not to be inhibited (Temonen et al., 1995). Avail- noblotting or in guanidinium thiocyanate solution for RNA
ability of other MxA-expressing cell lines, like Vero cells, isolation and Northern blotting (Chomczynski and Sacchi,
the sensitivity of other members of the Bunyaviridae fam- 1987). Cells grown on coverslips were infected, fixed
ily to MxA protein (Frese et al., 1996), and a newly discov- with 3% paraformaldehyde, and permeabilized with 0.1%
ered PUUV relative, TULV, prompted us to look in more Triton X-100 for immunofluorescence. Conditioned cell
detail at the sensitivity of PUUV and TULV to MxA protein. culture medium was collected for the determination of
virus yields. Virus titers were determined by immunofluo-
MATERIALS AND METHODS rescence plaque assay as described (Temonen et al.,
1995).Cells
Permanently MxA-transfected African green monkey Immunoblotting
kidney (Vero) cells (clones VA9 and VA12) and control
cells (clones VN5 and VN36) were kindly provided by Immunoblotting was done as described (Temonen et
al., 1995). The protein concentration of the samples wasDr. Otto Haller (Frese et al., 1996). Briefly, MxA gene is
expressed under the control of a constitutive 3-hydroxy-3- measured by BCA protein assay reagents (Pierce, Rock-
ford, IL) prior to the addition of Laemmli sample buffer.methylglutaryl coenzyme A reductase promoter. Control
cells had been transfected only with the neomycin resis- Polyclonal antibodies to MxA protein (Ronni et al., 1993)
and PUUV N protein (Vapalahti et al., 1995) and a hantavi-tance gene. The cells were propagated with Dulbecco’s
modified Eagle’s medium containing 10% fetal calf serum rus-specific monoclonal antibody, 1C12 (Lundkvist et al.,
1992), were used as primary antibodies. They were di-(FCS), 2 mM L-glutamine, 100 IU/ml penicillin and 50
mg/ml streptomycin, and 2.0 mg/ml G418 (GIBCO BRL, luted 1:500 (anti-MxA), 1:250 (anti-PUUV N), or 1:150
(1C12) in PBS supplemented with 5% nonfat milk. Anti-Berlin, Germany). Monocytic U-937 cell clones 1 and 4,
stably transfected with the MxA gene, and a MxA-nega- rabbit IgG or anti-mouse IgG were used as secondary
antibodies at a dilution of 1:1000. The bands were visual-tive control clone 8, were kindly provided by Dr. Sibylle
Schneider-Schaulies (Schnorr et al., 1993). The cells ized with the ECL reagents (Amersham, Buckingham-
shire, England) and the optical density of the bands waswere propagated in RPMI 1640 supplemented as de-
scribed above, with 0.2 mg/ml G418. In order to differenti- quantified with a Millipore BioImage scanner (Millipore,
Bedford, MA).ate U-937 cells, they were treated with 10 ng/ml phorbol
12-myristate 13-acetate (PMA; Sigma, St Louis, MO) for Purified MxA protein (Ronni et al., 1993) was used to
estimate MxA protein levels in various cell lines.24 hr. During PMA treatment 80% of cells became adher-
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Immunofluorescence
For immunofluorescence primary antibodies as de-
scribed above were used in 1:50 to 1:15 dilutions in PBS.
Species-specific FITC-conjugated secondary antibodies
were used in 1:30 dilution.
Northern blotting and RNA hybridization
Total cell RNA was extracted from infected cells and
control cells by the guanidinium thiocyanate–phenol–
chloroform method (Chomczynski and Sacchi, 1987).
Samples of RNA (10–20 mg) were electrophoresed on
1.2% agarose formaldehyde gel and blotted on Hybond-
C membranes (Amersham) followed by UV cross-linking
(Stratagene, La Jolla, CA). Prehybridization (for 3 hr) and
hybridization (overnight) with radiolabeled cDNA probes
were performed at 427 in a solution containing 50% for-
mamide, 50 mM HEPES (pH 7.2), 31 SSC, 11 Denhardt’s
solution, and 200 mg/ml salmon sperm DNA. Filters were
washed under stringent conditions (in 11 SSC and 0.1%
SDS for 2 1 10 min at room temperature and for 3 1 15
min at 657), and exposed to Fuji medical X-ray film RX
(Tokyo, Japan) at 0707 with an intensifying screen. Opti-
cal densities of the Northern blotting bands were quanti-
fied by BioImage scanner.
Preparation of [a-32P]dCTP-labeled cDNA probes
Gel-purified 1.3- and 3.6-kb cDNA inserts of PUUV S
and M segments (Vapalahti et al., 1992), respectively,
were labeled with [a-32P]dCTP (Amersham) by Ready to FIG. 1. PUUV infection in MxA-transfected Vero cell clones (VA9 and
VA12) and control cell clones (VN5 and VN36). Different Vero cell clonesGo DNA labeling kit (Pharmacia, Uppsala, Sweden) ac-
were infected with PUUV and cells were collected at times indicated.cording to the manufacturer’s instructions. Free nucleo-
Protein samples (10 mg) were separated on 10% SDS–PAGE, trans-
tides were removed by nick column (Pharmacia). TULV- ferred to nylon filters, and stained with anti-PUUV N antibodies followed
specific probes were produced similarly using 1.8-kb S- by secondary antibodies. The bands were visualized with the ECL
segment, 1.8-kb M-segment, and 0.94-kb L-segment chemiluminescence system. E6 / PUU represents Vero E6 cells in-
fected with PUUV as a positive control for the nucleocapsid protein.cDNA fragments (Plyusnin et al., 1994, 1996; Vapalahti
The histograms show the intensities of the PUUV N-specific bands.et al., in press). The GAPDH gene (Fort et al., 1985) was
used as a constant probe.
was also seen at 8 days postinfection in the cell clone
RESULTS VN36 (Fig. 1). The difference in N protein level between
clones VN5 (MxA-negative) and VA9 (MxA-positive) wasInhibition of PUUV and TULV replication in MxA-
maximally sevenfold on Day 8 postinfection.expressing Vero cells
In immunofluorescence (IF), 95–100% of the MxA-
transfected cells (VA9 and VA12) showed strong MxA-In order to analyze the effect of MxA protein on the
replication of PUUV and TULV, MxA-overexpressing Vero specific staining (data not shown). In IF, the number of
PUUV N-positive cells was reduced in MxA-expressingcell clones were infected with these viruses. PUUV N
protein accumulation was found to be suppressed in Vero cells compared to MxA-negative control cells (Table
1). IF studies also showed that PUUV propagated rela-MxA-positive cell clones (VA9 and VA12) compared to
MxA-negative control Vero cell clones (VN5 and VN36), tively slowly in all Vero cell clones. In 8 days only 40%
of VN5 cells showed PUUV N-specific staining; by thissuggesting that MxA protein was capable of inhibiting
PUUV N protein accumulation in these cells (Fig. 1). time Vero E6 cells show 100% infection (Temonen et al.,
1993). The slow rate of infection in Vero cells possiblyPUUV replication in these cells was slow and the differ-
ence in N protein accumulation between MxA-positive explains why the inhibitory effect of MxA protein on PUUV
N protein accumulation is not seen until several daysand -negative cell clones was evident starting at 4 days
postinfection in the MxA-negative cell clone VN5 and it after infection. There may also be clonal differences in
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TABLE 1
Percentage of PUUV N-Positive Cells 1–9 Days Postinfection
Cell clone MxA 1 2 4 6 9 p.ia
VN5 0 1 5 5–10 10–20 40
VN36 0 1 1 1 1 1–5
VA9 / 1 1 1 1 1
VA12 / 1 1 1 1 1
a p.i., postinfection.
Vero cell clones since PUUV appeared to grow differently
in MxA-negative VN5 and VN36 cell clones (Fig. 1). Simi-
FIG. 3. TULV infection in MxA-transfected Vero cell clones. Differentlar differences were also seen in the case of HTNV (Frese
Vero cell clones were infected with TULV and cells were collected atet al., 1996), but since HTNV replicated more rapidly than times indicated. Protein samples (7.5 mg) were analyzed by immu-
PUUV in these cells, the phenomenon was not as clearly noblotting using 1C12 monoclonal antibody, which recognized TULV N
seen in the case of HTNV (Frese et al., 1996). protein, as the first antibody. E6 / PUU represents Vero E6 cells in-
fected with PUUV as a positive control for the nucleocapsid protein.The yield of infectious virus from Vero VN5 cell clone
Densitometric analysis of TULV N protein band intensities in immu-was low, but reached a mean level of 2 1 102 PFU/ml
noblotting are shown at the bottom.on Day 8 in five separate experiments (Fig. 2). However,
in MxA-expressing cell lines the yields of infectious virus
were nearly undetectable (Fig. 2). was inhibited. Northern blotting data showed that al-
Next we wanted to study whether the replication of though PUUV and TULV N protein accumulation was not
TULV was also inhibited in MxA-expressing Vero cell fully inhibited in MxA-expressing cells (Figs. 1 and 3),
clones. TULV appeared to grow slightly better in Vero the accumulation of viral RNAs of S and M segments
cells than PUUV partly due to the higher infective dose. (PUUV and TULV) and of L segment (TULV) were clearly
Based on the accumulation of TULV N protein, the pro- inhibited in these cells (Fig. 4). No differences were seen
duction of viral proteins was clearly inhibited (Fig. 3). At in the relative amount of MxA protein-mediated inhibition
Days 3 and 5 after infection TULV N was hardly detect- between S or M or L segments of TULV. In PUUV infection
able in MxA-positive cells, whereas in MxA-negative cell only S and M segment RNAs could be visualized,
lines high levels of N protein was seen. The difference whereas all three TULV segments were clearly detect-
in N protein accumulation between clones VN5 and VA12 able in MxA-negative cells (Fig. 4), further supporting the
was more than 100-fold at Day 5 after infection (Fig. 3). observation that TULV replicated better than PUUV in
To further characterize the inhibition of PUUV and Vero cells.
TULV replication by MxA protein we carried out Northern
Effect of MxA protein on PUUV and TULVblotting experiments to see whether viral RNA synthesis
in U-937 cells
The effect of MxA protein on PUUV and TULV infection
in MxA-transfected U-937 cell clones was tested (data
not shown). The results were essentially similar to those
published earlier for PUUV (Temonen et al., 1995). There
was no evidence that MxA protein expression in PMA-
treated or untreated U-937 clones 1 and 4 (MxA/) could
inhibit PUUV or TULV infection in comparison to the con-
trol clone 8 (MxA0) as seen by the level of N-protein
accumulation (data not shown). However, the rate of
PUUV and TULV infections in all U-937 cell clones was
low, less than 1% of cells were infected as judged by
immunofluorescence analysis (data not shown). More-
over, accumulation of N protein, along with the time post-
infection, was very modest as analyzed by immunoblot-
ting, suggesting that all U-937 clones can only poorly
FIG. 2. Production of infectious PUUV in MxA-transfected and control
support the growth of these viruses. No production ofVero cell lines. Cells were infected with PUUV and culture supernatants
infectious viruses could be detected by the IF-plaquewere collected at times indicated and stored at 0707. The virus yields
were measured in Vero E6 cells by IF-plaque assay. method in U-937 cell cultures.
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FIG. 4. Northern blot analysis of PUUV and TULV RNA expression in MxA-transfected and control Vero cell clones. Vero cells were infected with
PUUV (A) or TULV (B) and the cells were collected at times indicated. Total cellular RNA was isolated and 10 mg (20 mg for PUUV M) of total cell
RNA was separated on agarose gels and transferred to nylon filters. Hybridization was performed with radioactive cDNA probes of S and M
segments of PUUV (A) and for S, M, and L segments of TULV (B) detecting 1.3-, 3.6-, and 6.5-kb RNA fragments, respectively. GAPDH was used
as a constant probe. Optical densities of viral RNA bands were measured from original autoradiograms and are shown as histograms in relation
to standardization with GAPDH mRNA levels. Note a different scale of ODs in A and B.
To consider the possibility that MxA protein levels var- in PBMC and A549 lung carcinoma cell line before and
after induction with a high concentration (1000 IU/ml)ied between different MxA-positive Vero and U-937
clones and to compare MxA levels of transfected cell of IFN-a for 24 hr. Quantitative analysis (Figs. 5A–5D)
showed that the MxA-transfected U-937 cell clones 4 andlines to the ones found after IFN-a induction, we carried
out MxA protein quantitation by immunoblotting. Different 1 expressed lower (3 ng/mg), whereas Vero cell clones
VA9 and VA12 expressed higher levels of MxA proteinamounts of total cell proteins from Vero (Fig. 5B) and U-
937 (Fig. 5C) clones were analyzed by immunoblotting. (10 ng/mg) than PBMC or A-549 cells after IFN-a induc-
tion (3 ng/mg).For comparison, Fig. 5A shows the levels of MxA protein
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DISCUSSION
Recent evidence suggests that the replication of sev-
eral members of the Bunyaviridae family is inhibited by
MxA protein (Frese et al., 1996). Here we show that PUUV
and its presumably apathogenic relative TULV are also
inhibited in stably transfected MxA-expressing Vero
cells.
The accumulation of PUUV N protein was clearly inhib-
ited in MxA-positive cell lines at late times of infection,
but it was not complete. Minute amounts of N protein
originating either from the input virus or from viral protein
synthesis, which evidently took place also in MxA-posi-
tive cells, were visualized in immunoblotting with anti-N
protein staining (Fig. 1). These results are in line with
those of HTNV infection in the same Vero cell lines (Frese
et al., 1996). Despite the low level of PUUV protein syn-
thesis in VA9 and VA12 MxA-positive cell lines, the pro-
duction of infectious virus was almost completely inhib-
ited. Only few PFU/ml of PUUV were found in contrast to
tens (VN36) or hundreds (VN5) of PFU/ml in control cell
lines. This was constantly seen in several different exper-
iments and clearly indicates that a marked, up to a 100-
fold, inhibition in the production of infectious virus was
seen by MxA protein. This difference is higher than what
could be expected from the accumulation of PUUV N
protein. Thus it is possible that the accumulation of other
viral proteins such as envelope glycoproteins was more
drastically inhibited, a phenomenon demonstrated to oc-
cur in measles virus-infected MxA-expressing U-937
cells (Schnorr et al., 1993). We were unable to detect any
PUUV glycoproteins by immunoblotting in any of the Vero
cell lines, which suggests that either the PUUV glycopro-
tein expression levels were extremely low or that our
antibodies did not reach very high sensitivity in immu-
noblotting. TULV, which seemed to replicate better than
PUUV in Vero cell clones, was readily inhibited in MxA-
positive cell lines as judged by the accumulation of TULV
N protein. Hardly any TULV N protein was seen in MxA-
positive clones, whereas high levels of N protein were
seen in control cell lines (Fig. 3). All this suggests that
the better the virus replicates in a given cell line the
better MxA protein-mediated inhibition in virus replica-
tion is seen.
In order to analyze whether PUUV and TULV were also
inhibited at a transcriptional level, Northern blot analyses
FIG. 5. Quantitative immunoblotting analysis of MxA protein levels were carried out. In MxA-positive cell clone VA12 the
in different cell lines. Protein samples (10, 3, and 1 mg) from different steady-state PUUV S and M segment RNA levels were
cell lines (as indicated) were separated in SDS – PAGE, transferred almost completely undetectable, only very weak bands
to nylon membranes, and stained with rabbit anti-MxA protein
were seen at Day 5 postinfection. In the case of TULV(Ronni et al., 1993) followed by band visualization with the ECL
infection, the difference between MxA-positive and -neg-reagent. The band intensities were determined with Millipore Bio-
Image scanner and the relative levels of MxA protein in different ative cell lines was even more pronounced. A full inhibi-
cell lines are shown (D). MxA protein levels in IFN-a treated PBMC tion of accumulation of all viral RNA segments was seen
is given a value of 1. For comparison, pure MxA protein (10, 3, and
in VA12 (MxA/) cell line (Fig. 4), a result that very well1 ng) was used to obtain absolute amounts of MxA protein in cell
matched with the lack of TULV N protein expression inlines. In all cell clones only the 76-kDa full-length form of MxA
protein was scanned. MxA-positive cells (Fig. 3). Our Northern data suggest
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that the replication and RNA synthesis of PUUV and IFNs and MxA protein especially can inhibit the replica-
tion of at least two pathogenic hantaviruses (Tamura etTULV, and not just viral protein synthesis, are inhibited
by MxA protein in Vero cells. Similar to Hantaan, but al., 1987; Temonen et al., 1995) still holds promise for
therapeutic intervention in severe hantavirus infectionsunlike La Crosse and Rift Valley fever viruses (Frese et
al., 1996), there did not seem to be any selectivity in caused by HTNV, PUUV, or even SNV if the timing and
dosage of IFN treatment are reevaluated.MxA-dependent inhibition of the different RNA segments
of PUUV and TULV. Due to the low stock PUUV and TULV
titers and slow pace of infection it was, however, not ACKNOWLEDGMENTS
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